Perceptive Advisors - BRAINSTORM CELL THERAPEUTICS C ownership

Back to all holdings Add to watchlist

BRAINSTORM CELL THERAPEUTICS C's ticker is BCLI and the CUSIP is 10501E102. A total of 1 filers reported holding BRAINSTORM CELL THERAPEUTICS C in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Links
Filings
External links
Quarter-by-quarter ownership
Perceptive Advisors ownership history of BRAINSTORM CELL THERAPEUTICS C
ValueSharesWeighting
Q1 2017$1,700,000
+76.3%
400,0000.0%0.10%
+56.5%
Q3 2016$964,000
-15.7%
400,0000.0%0.06%
-27.1%
Q4 2015$1,144,000–400,000–0.08%–
 Download
Other shareholders
BRAINSTORM CELL THERAPEUTICS C shareholders Q3 2016
NameSharesValueWeighting ↓
Perceptive Advisors 400,000$964,0000.06%
View complete list of BRAINSTORM CELL THERAPEUTICS C shareholders